实用医学杂志 ›› 2022, Vol. 38 ›› Issue (2): 206-211.doi: 10.3969/j.issn.1006⁃5725.2022.02.015

• 药物与临床 • 上一篇    下一篇

醒脑静注射液联合阿替普酶治疗缺血性脑卒中疗效和安全性的系统评价

郭飞1 黄云慧2 黄宇靖1 牛慧芳3 杜爱玲1   

  1. 1 新乡医学院第二附属医院(河南新乡 453002);2 新乡市第一人民医院(河南新乡453000);3 新乡医学院 (河南新乡 453003)

  • 出版日期:2022-01-25 发布日期:2022-01-25
  • 通讯作者: 杜爱玲 E⁃mail:duailing827@163.com
  • 基金资助:
    河南省医学科技攻关计划项目(编号:2018020372)

Systematic review of efficacy and safety of xingnaojing injection combined with alteplase for ischemic stroke

GUO Fei*,HUANG Yunhui,HUANG Yujing,NIU Huifang,DU Ailing.    

  1. The Second Affiliated Hospital of Xinxiang Medical University,Xinxiang 453002,China

  • Online:2022-01-25 Published:2022-01-25
  • Contact: DU Ailing E⁃mail:duailing827@163.com

摘要:

目的 系统评价醒脑静注射液联合阿替普酶治疗缺血性脑卒中的疗效和安全性。方法 计算机检索中国知网、万方、VIP、CBM、PubMed、The Cochrane Library、Embase,系统收集有关醒脑静注射液 联合阿替普酶治疗缺血性脑卒中的随机对照研究,纳入 9 项研究涉及 1 005 例患者,并采用 RevMan 5.3 件对纳入的相关研究进行 Meta 分析。结果 与对照组相比,观察组的有效率增加;NIHSS 评分、NDS 分、缺血面积、TNF⁃α、PS、hs⁃CRP、IL⁃1、IL⁃6、IL⁃8 水平降低;MoCA 评分、ADL 评分以及基底动脉、大脑中动 脉左侧、大脑中动脉右侧、大脑前动脉左侧、大脑前动脉右侧、大脑后动脉左侧、大脑后动脉右侧、椎动脉 左侧和椎动脉右侧血流速度升高;且两组不良反应发生率无显著差异。结论 当前证据显示,醒脑静注 射液联合阿替普酶对缺血性脑卒中患者有较好的疗效和安全性,但受纳入研究的质量和数量限制,所得 结论仍需高质量的多中心、双盲临床随机对照试验予以验证。

关键词:  , 醒脑静注射液,  , 阿替普酶,  , 缺血性脑卒中,  , 认知功能,  , 神经功能,  , Meta 分析

Abstract:

Objective To systematically evaluate the efficacy and safety of xingnaojing injection combined with alteplase for ischemic stroke. Methods By searching CNKI,Wanfang,VIP,CBM,PubMed,The Cochrane Library,Embase,randomized controlled studies on xingnaojing injection combined with alteplase for ischemic stroke were systematically collected.A total of 9 studies were included,involving 1005 patients. Meta ⁃analysis of the included related studies was performed by using RevMan 5.3 software. Results Meta⁃analysis showed that the effective rate of the observation group was higher than that of the control group after treatment. NIHSS degree NDS degree,Ischemic area,TNF⁃ α,PS,IL⁃8,hs⁃CRP,IL⁃1 and IL⁃6 were lower than those of the control group. MoCA score and ADL score were higher than those of the control group. Meanwhile,the blood flow velocity in basilar artery,middle cerebral artery,anterior cerebral artery,posterior cerebral artery and vertebral artery were higher than those of the control group. Adverse event incidence was not statistically different between the two groups. Conclusion The current evidence showedxingnaojing injection combined with alteplase had better cura⁃ tive effect and safety in patients with cerebral infarction. However,the obtained conclusions needed to be validated by high ⁃ quality multi ⁃ center,double ⁃ blind clinical randomized controlled trials,due to the limited quality and quantity of the included studies.

Key words:

xingnaojing injection, alteplase, ischemic stroke, cognitive function, neurologic func? tion, meta?analysis